T134 [8122]



T134


SMILES N=C(N)NCCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N1)C(=O)O
InChIKey ZFIUCXJWTNZDRW-UYROLUPNSA-N
Sequence RRWCYRKKPYRXCR
HELM PEPTIDE1{R.R.W.C.R.Y.R.K.[dK].P.Y.R.[Cit].C.R}$PEPTIDE1,PEPTIDE1,4:R3-14:R3$$$

Chemical Properties

Hydrogen bond acceptors 29
Hydrogen bond donors 40
Rotatable bonds 51
Log P -8.007
Molecular weight (Da) 2181.2
Stereochemistry info unspecified

Database connections

Model (AF2) CXCR4


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

T134


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) CXCR4


Compound is not listed as a drug.